NEURIX specializes in human neural organoid models to advance drug discovery, toxicity screening and disease modelling. Using induced pluripotent stem cell (iPSC)-derived technology, we offer cutting-edge platforms for glioblastoma, blood-brain barrier, Parkinson’s, and Alzheimer’s research. Our scalable, predictive models accelerate scientific breakthroughs, de-risk drug development, and support therapeutic innovation with unparalleled human relevance.
